Engaging Community Pharmacists in Improving Treatment Outcomes for Patients with Opioid Use Disorder https://forefdn.org/grantee-spotlight-engaging-community-pharmacists-in-improving-treatment-outcomes-for-patients-with-opioid-use-disorder/ In late 2022, Congress passed legislation allowing any DEA-registered prescriber to prescribe buprenorphine for the treatment of opioid use disorder. Only around half of U.S. pharmacies stock it, however, because of controlled substance purchasing and dispensing requirements. Today, the National Association […]
Filed under: General Problems | Leave a Comment »

















